Evaluation of Lines of Therapy Amongst Patients with NSCLC Tested with a Host Immune Classifier (HIC) in a Real-World Setting

被引:0
|
作者
Iams, Wade [1 ]
Le, Kimberly [2 ]
Princic, Nicole [3 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Biodesix Inc, Boulder, CO USA
[3] Merative, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PP01.16
引用
收藏
页码:E14 / E15
页数:2
相关论文
共 50 条
  • [21] A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC
    Morimoto, Kenji
    Sawada, Ryo
    Yamada, Tadaaki
    Azuma, Koichi
    Ito, Kentaro
    Goto, Yasuhiro
    Kimura, Hideharu
    Harada, Taishi
    Shiotsu, Shinsuke
    Tamiya, Nobuyo
    Chihara, Yusuke
    Takeda, Takayuki
    Hiranuma, Osamu
    Hasegawa, Isao
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (09):
  • [22] Evaluation of Clinical Remission Indicators in Asthma Patients Treated With Biologics in a Real-world Setting
    Lim, K. G.
    Corbridge, T.
    Lee, L.
    Barman, H.
    Manoharan, M.
    Simsek, S.
    Wagner, T.
    Deb, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [23] Later lines of systemic therapy in patients with metastatic colorectal cancer: real-world data from a setting with barriers to access cancer therapies
    Jacome, Alexandre A.
    Mathias-Machado, Maria Cecilia
    Gil, Mariana
    Passarini, Thais M.
    Cristofaro, Sabrina
    Moraes, Eduardo D.
    Freitas, Laura V. W.
    Prolla, Gabriel
    Amorim, Larissa C.
    Paes, Rafael D.
    Gasparotto, Bianca
    Canedo, Jorge
    Ferreira, Carlos Gil
    Ferrari, Bruno
    Garicochea, Bernardo
    Gil, Roberto
    Peixoto, Renata D'Alpino
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (06)
  • [24] Combination therapy prescribing in pulmonary arterial hypertension patients in a real-world setting in Latin America
    Pineda, T.
    Bennett, A.
    Bluro, I.
    Harley, J.
    Irias, J.
    Pulido, T.
    Ramirez, A.
    Rozo Bedoya, C.
    Small, M.
    Orozco-Levi, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [25] Real-World Data on Prognostic Factors for Overall Survival in NSCLC Patients Treated with Bevacizumab Combination Therapy
    Wu, S.
    Liao, W.
    Ho, C.
    Shih, J.
    Yu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S626 - S626
  • [26] Investigation of Blood Pressure Control in Hypertensive Patients with and without Antithrombotic Therapy in a Real-World Setting
    Odaguchi, Naoyuki
    Sakima, Atsushi
    Nakada, Seigo
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2021, 43 (03) : 263 - 269
  • [27] Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine
    D Weycker
    J Edelsberg
    G Vincze
    S E Kjeldsen
    K Jamerson
    Z M Khan
    G Oster
    Journal of Human Hypertension, 2007, 21 : 374 - 380
  • [28] Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine
    Weycker, D.
    Edelsberg, J.
    Vincze, G.
    Kjeldsen, S. E.
    Jamerson, K.
    Khan, Z. M.
    Oster, G.
    JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (05) : 374 - 380
  • [29] Clinical heterogeneity of elderly melanoma patients in the real-world setting: Potential implications for treatment outcomes following immune based therapy.
    Hegde, Upendra P.
    Parmar, Harsh V.
    Stevenson, Christina Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors
    Ariyasu, Ryo
    Kakuto, Sho
    Miyadera, Keiki
    Akita, Takahiro
    Kiritani, Ayu
    Tsugitomi, Ryosuke
    Amino, Yoshiaki
    Uchibori, Ken
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (06):